On May 14, 2026, Biogen Inc. announced the successful completion of its acquisition of Apellis Pharmaceuticals, Inc., which is now... Read more
Category: Uncategorized
IQVIA and Kexing Biopharm Expand Strategic Collaboration for AI-Powered Biosimilar Development
IQVIA and Kexing Biopharm have announced an expansion of their strategic collaboration to support a global, multi-product biosimilar development and... Read more
Dr. Pham Thanh Viet Appointed as Director of Cho Ray Hospital
On May 14, 2026, the Ministry of Health officially announced the appointment of Dr. Pham Thanh Viet as the new... Read more
Beyond Behavior: Why High-Impact Leaders Are Often Misjudged
In the complex landscape of organizational development, a troubling paradox persists: the most effective, results-driven executives are frequently the ones... Read more
BMS and Hengrui Pharma Form Multi-Billion Strategic Alliance for 13 Early-Stage Programs
Bristol Myers Squibb (BMS) and Hengrui Pharma have entered into a major global strategic collaboration to advance a portfolio of... Read more
OrganaBio Acquires Excellos Assets to Establish Coast-to-Coast Cell Therapy CDMO
OrganaBio has announced the substantial acquisition of all operating assets from San Diego-based Excellos. This move officially establishes a bicoastal... Read more
AstraZeneca Licenses Owkin’s AI Scientist to Develop Novel Biopharma Agents
AstraZeneca has entered into a three-year licensing agreement to integrate K Pro, Owkin’s "AI Scientist," into its IT infrastructure and... Read more
EU Expands Indication for Pfizer’s Hympavzi to Treat Hemophilia A and B with Inhibitors
The European Commission (EC) has granted marketing authorization to expand the approved indication for Hympavzi (marstacimab). The expansion now covers... Read more
Lilly’s Data Highlights ‘Maintenance’ Strategies for GLP-1 Weight Loss
Eli Lilly has released new data addressing a fundamental hurdle in obesity treatment: weight regain after discontinuing GLP-1 therapy. The... Read more









